Interested to Buy Any Domain ? << Click Here >> for more details...
How you will select the runtime in HPLC for a drug in
method development.
- 6 Answers
- 22157 Views
- Aurobindo, GVK, Lesanto Laboratories, I also Faced
- E-Mail Answers
Answer Posted / ankur dwivedi
There is no any thumb rule that the runtime should be 3
times than main peak, but also depends on the late eluting
impurities in compound; which should be confirmed at the
time of method development. Considering all these, the run
time should be selected.
Ankur Dwivedi
ZCL Chemicals, Ankleshwar
| Is This Answer Correct ? | 24 Yes | 1 No |
Post New Answer View All Answers
How can we confirm the HPLC column is end-capped or not? Is it possible to identify by physical appearance?
why cone formation during dissolution?
identification is for unknown? qualification for known? reporting for LOQ?
WHY pKa value is more important than pH value of the mobile phase in HPLC?
What is the formula for relative diffrence for standard solution in solution stability in validation?
what is the extinction coefficient for Indomethacin or at 319nm wave length.
How doing qbd practically?
what is third integration
in DMF having extra impurities and in api COA also having extra imp than USP or BP product then how require to proceed?
please explian me about area normalisation method,diluted standard method,impurity vs impurity and which one has to be selected in method development
we are performed SOR for a particular product the limit is -6 to -10.We face particular bathes it is not meeting the specification.we performed diffrent instrument diffrent analyst we are getting diffrent diffrent results.solvent is dimethyl sulfoxide what could be the reasion
Difference between the quantitative analysis and qualitative analysis?
What is the principle of Thermal conductivity detector and FID?
what is impurity profile. how to interpret this impurity profile to a drug product or drug substance.
How to choose the which salt is suitable for mobilephase
